Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fed2b7de0f46aff7b08dd465a2841e2 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
filingDate |
2012-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78573066170b96bd4acfa9106cbf0ccb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9c4047b54b615e7b35be7e3e8cc2ee1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e822c7dc49fc495d940b43e3b3e1c73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ca63d9b03e77eb4c89d89abf681c08a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8e1337a4dd43d84bfde5aefdf2263b5 |
publicationDate |
2012-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2837429-A1 |
titleOfInvention |
Pharmaceutical composition comprising a trpa1 antagonist and a beta-2 agonist |
abstract |
The present patent application relates to a pharmaceutical composition comprising a transient receptor potential ankyrin-1 receptor ("TRPA1") antagonist and a beta-2 adrenergic receptor agonist ("beta-2 agonist"). |
priorityDate |
2011-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |